Regulated medicine supply
Chemovar
Linking order records, traceability and reporting
Engineering contribution reported by Lifon Labs · Source review: 5 November 2026
The need
A medicine-supply platform needs to connect stock, orders and fulfilment while limiting what each audience can see. Historical stock positions also matter when preparing reports.
The approach
Lifon Labs describes contributing to role-scoped access, batch and permit records, controlled order transitions and reporting generated from completed orders.
What was delivered
- Pharmacy-specific catalogues and quantity-based pricing.
- Order, payment, invoice and shipment records.
- Activity history and exports built from recorded transactions.
Result and evidence
The source describes an engineering contribution in Australia’s regulated medicine supply chain. This case study does not independently establish regulatory approval, legal compliance or permission to supply medicines.

Sources and attribution
Delivery details and scope counts are reported by Lifon Labs. They have not been independently audited by MOVE.
- Lifon Labs: original Chemovar case study ↗
- Existing MOVE portfolio entry, retained at this address; editorial summary updated 5 November 2026.
Work may have been completed through the contributor’s own business or earlier engagements. Inclusion does not imply a direct MOVE contract or client endorsement. Current product operation and business outcomes require separate evidence.
